Abingworth Raises $465m To Back And Build New Biotechs

Largest UK-Based Life Sciences Venture Fund

The ABV 8 fund will invest $15m to $30m per company across the range from start-ups to development-stage companies.

US dollars
returns for biotech have been excellent for the last 10 years • Source: Shutterstock

More from Financing

More from Business